Jung-Seok Choi Selected Research

Substance Withdrawal Syndrome (Withdrawal Symptoms)

1/2018	Role of Frontostriatal Connectivity in Adolescents With Excessive Smartphone Use.
4/2014	Comparison of the effectiveness of virtual cue exposure therapy and cognitive behavioral therapy for nicotine dependence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jung-Seok Choi Research Topics

Disease

11	Alcoholism (Alcohol Abuse) 02/2024 - 12/2014
6	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2018 - 11/2009
5	Schizophrenia (Dementia Praecox) 11/2016 - 04/2006
4	Mental Disorders (Mental Disorder) 01/2021 - 05/2017
4	Cognitive Dysfunction 06/2018 - 12/2016
3	Gambling (Pathological Gambling) 03/2016 - 12/2014
3	Psychotic Disorders (Schizoaffective Disorder) 12/2009 - 04/2006
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2018 - 04/2014
2	Substance-Related Disorders (Drug Abuse) 01/2016 - 07/2015
1	Neuroblastoma 06/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 06/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2018
1	Disease Progression 10/2017
1	Hepatitis C 05/2017
1	Chronic Hepatitis C 05/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2017
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2016
1	Anosmia 01/2016
1	Tobacco Use Disorder (Nicotine Dependence) 04/2014
1	Hyponatremia 03/2012
1	Medically Unexplained Symptoms 03/2012
1	Major Depressive Disorder (Major Depressive Disorders) 12/2009
1	Prodromal Symptoms 11/2008
1	Congenital Abnormalities (Deformity) 08/2007
1	Weight Loss (Weight Reduction) 04/2006
1	Weight Gain 04/2006

Drug/Important Bio-Agent (IBA)

22	Immunoglobulin D (IgD)IBA 02/2024 - 12/2014
5	Biomarkers (Surrogate Marker)IBA 06/2018 - 12/2009
2	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 01/2019
2	Antipsychotic Agents (Antipsychotics)IBA 11/2015 - 11/2008
1	Ethanol (Ethyl Alcohol)IBA 06/2022
1	RNA (Ribonucleic Acid)IBA 06/2022
1	KynurenineIBA 01/2022
1	N 30IBA 01/2022
1	Cilostazol (Pletal)FDA LinkGeneric 01/2019
1	Donepezil (Aricept)FDA LinkGeneric 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2018
1	InterferonsIBA 05/2017
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2016
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2016
1	Corticotropin-Releasing HormoneIBA 01/2016
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2016
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2016
1	Paliperidone Palmitate FDA Link 11/2015
1	Carbon MonoxideIBA 04/2014
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 03/2012
1	Inositol (Myoinositol)IBA 12/2009
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 11/2009
1	antiarrhythmic peptide (AAP)IBA 11/2009
1	Protons (Proton)IBA 06/2009
1	N-acetylaspartate (N-acetyl aspartate)IBA 06/2009
1	Complement System Proteins (Complement)IBA 08/2007
1	Olanzapine (Zyprexa)FDA Link 04/2006

Therapy/Procedure

3	Therapeutics 01/2021 - 11/2008
1	Lymph Node Excision (Lymph Node Dissection) 01/2022
1	Transcranial Direct Current Stimulation 01/2021
1	Activities of Daily Living (ADL) 01/2019
1	Meditation 03/2018
1	Renal Dialysis (Hemodialysis) 03/2018
1	Vocational Rehabilitation 11/2016
1	Injections 11/2015
1	Aftercare (After-Treatment) 04/2014
1	Drug Therapy (Chemotherapy) 05/2011